|国家科技期刊平台
| 注册
首页|期刊导航|肿瘤学与转化医学（英文）|EZH2 is a biomarker associated with lung cancer diagnosis and immune infiltrates without prognostic specificity: a study based on the cancer genome atlas data

EZH2 is a biomarker associated with lung cancer diagnosis and immune infiltrates without prognostic specificity: a study based on the cancer genome atlas data

Xiaokun Wang Min Qi Xu Zhu Zhengtong Zhao Yufeng Cao Daijun Xing Fuman Wang Gaoyang Lin

肿瘤学与转化医学（英文）2023，Vol.9Issue(3)：99-114,16.
✕
肿瘤学与转化医学（英文）2023，Vol.9Issue(3)：99-114,16.DOI:10.1007/s10330-022-0599-9

EZH2 is a biomarker associated with lung cancer diagnosis and immune infiltrates without prognostic specificity: a study based on the cancer genome atlas data

EZH2 is a biomarker associated with lung cancer diagnosis and immune infiltrates without prognostic specificity: a study based on the cancer genome atlas data

Xiaokun Wang 1Min Qi 2Xu Zhu 3Zhengtong Zhao 3Yufeng Cao 4Daijun Xing 4Fuman Wang 3Gaoyang Lin3

作者信息

  • 1. Cardiac Center(Department of Vascular Surgery),The Affiliated Qingdao Hiser Hospital of Qingdao University(Qingdao Hospital of Traditional Chinese Medicine),Qingdao 266033,China
  • 2. Department of Clinical Laboratory,The Affiliated Qingdao Hiser Hospital of Qingdao University(Qingdao Hospital of Traditional Chinese Medicine),Qingdao 266033,China
  • 3. Department of Cardiothoracic Surgery,The Affiliated Qingdao Hiser Hospital of Qingdao University(Qingdao Hospital of Traditional Chinese Medicine),Qingdao 266033,China
  • 4. Department 3 of the Cancer Center,The Affiliated Qingdao Hiser Hospital of Qingdao University(Qingdao Hospital of Traditional Chinese Medicine),Qingdao 266033,China
  • 折叠

摘要

关键词

Enhancer of zeste homolog 2/lung cancer/diagnosis/prognosis/immune infiltrating

Key words

Enhancer of zeste homolog 2/lung cancer/diagnosis/prognosis/immune infiltrating

引用本文复制引用

Xiaokun Wang,Min Qi,Xu Zhu,Zhengtong Zhao,Yufeng Cao,Daijun Xing,Fuman Wang,Gaoyang Lin..EZH2 is a biomarker associated with lung cancer diagnosis and immune infiltrates without prognostic specificity: a study based on the cancer genome atlas data[J].肿瘤学与转化医学（英文）,2023,9(3):99-114,16.

基金项目

Supported by a grant from the Qingdao 2020 Medical Scientific Research Guidance Plan(No.2020-WJZD036). （No.2020-WJZD036）

肿瘤学与转化医学（英文）

OACSTPCD

2095-9621

访问量0
|
下载量0
段落导航相关论文